Evidence map›Paper›PMID 30545837›Full record

ArticleAJNR. American journal of neuroradiology2019

Brain β-Amyloid and Atrophy in Individuals at Increased Risk of Cognitive Decline.

I K Martikainen, N Kemppainen, J Johansson, J Teuho, S Helin, Y Liu, S Helisalmi, H Soininen, R Parkkola, T Ngandu and 2 more

Abstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Molecular Targets in Alzheimer's Disease.Molecular neurobiology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

I K MartikainenFrom the Department of Radiology (I.K.M.), Medical Imaging Center, Tampere University Hospital, Tampere, Finland ilkka.martikainen@pshp.fi.ORCID 0000-0002-6025-6994
N KemppainenDivision of Clinical Neurosciences (N.K., J.O.R.), Turku University Hospital, Turku, Finland.ORCID 0000-0002-8988-5858
J JohanssonTurku PET Centre (N.K., J.J., J.T., S. Helin, J.O.R.), University of Turku, Turku, Finland.ORCID 0000-0002-4501-4735
J TeuhoTurku PET Centre (N.K., J.J., J.T., S. Helin, J.O.R.), University of Turku, Turku, Finland.ORCID 0000-0001-9401-0725
S HelinTurku PET Centre (N.K., J.J., J.T., S. Helin, J.O.R.), University of Turku, Turku, Finland.ORCID 0000-0002-9405-7301
Y LiuDepartment of Neurology (Y.L., S. Helisalmi, H.S., M.K.), University of Eastern Finland, Kuopio, Finland.ORCID 0000-0003-2386-3370
S HelisalmiDepartment of Neurology (Y.L., S. Helisalmi, H.S., M.K.), University of Eastern Finland, Kuopio, Finland.ORCID 0000-0003-3982-2397
H SoininenDepartment of Neurology (Y.L., S. Helisalmi, H.S., M.K.), University of Eastern Finland, Kuopio, Finland.ORCID 0000-0002-2785-9937
R ParkkolaDepartment of Radiology (R.P.), University of Turku and Turku University Hospital, Turku, Finland.ORCID 0000-0001-8046-315X
T NganduDepartment of Public Health Solutions (T.N., M.K.), Public Health Promotion Unit, National Institute for Health and Welfare, Helsinki, Finland.ORCID 0000-0002-3698-2021
M KivipeltoDepartment of Neurology (Y.L., S. Helisalmi, H.S., M.K.), University of Eastern Finland, Kuopio, Finland.ORCID 0000-0003-0992-3875
J O RinneDivision of Clinical Neurosciences (N.K., J.O.R.), Turku University Hospital, Turku, Finland.ORCID 0000-0001-6369-0764

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeThe relationship between brain β-amyloid and regional atrophy is still incompletely understood in elderly individuals at risk of dementia. Here, we studied the associations between brain β-amyloid load and regional GM and WM volumes in older adults who were clinically evaluated as being at increased risk of cognitive decline based on cardiovascular risk factors. MATERIALS AND

methodsForty subjects (63-81 years of age) were recruited as part of a larger study, the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability. Neuroimaging consisted of PET using

resultsSixteen subjects were visually evaluated as showing cortical β-amyloid (positive for β-amyloid). In the voxel-by-voxel analyses, no significant differences were found in GM and WM volumes between the samples positive and negative for β-amyloid. However, in the sample positive for β-amyloid, increases in

conclusionsOur results show a significant association between increases in brain β-amyloid and reductions in regional GM volume in individuals at increased risk of cognitive decline. This evidence is consistent with a model in which increases in β-amyloid incite neurodegeneration in memory systems before cognitive impairment manifests.

Indexed as

AgedAged, 80 and overAmyloid beta-PeptidesAtrophyBrainCardiovascular DiseasesCognitive DysfunctionFemaleHumansImaging, Three-DimensionalMaleMiddle AgedNeuroimagingPositron-Emission TomographyRisk FactorsAmyloid beta-Peptides

Identifiers

PMID30545837
PMCPMC7048601

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.